Back to Journals » Cancer Management and Research » Volume 11

Erratum

L61H46 Shows Potent Efficacy Against Human Pancreatic Cancer Through Inhibiting STAT3 Pathway [Erratum]

       

Authors Bai E, Yang L, Xiang Y, Hu W, Li C, Lin J, Dai X, Liang G, Jin R , Zhao C 

Received 3 December 2019

Accepted for publication 3 December 2019

Published 23 December 2019 Volume 2019:11 Pages 10683—10684

DOI https://doi.org/10.2147/CMAR.S240955

Download Article [PDF] 


Bai E, Yang L, Xiang Y, et al. Cancer Manag Res. 2018;10:565–581.

During the publication process there was an operator error that resulted in the Western blot images of Figures 5A and 5B on page 575 appearing spliced.


Read the original article

Creative Commons License © 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]